Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: the Australian Trial in Acute Hepatitis C

BACKGROUND: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has been a concern that interferon-based HCV treatment may increase injecting risk behaviours. This study evaluated recent (past month) injecting risk behaviours during follow-up among PWID that did and d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Drug Policy
Autors principals: Alavi, Maryam, Spelman, Tim, Matthews, Gail V., Haber, Paul S., Day, Carolyn, van Beek, Ingrid, Walsh, Nick, Yeung, Barbara, Bruneau, Julie, Petoumenos, Kathy, Dolan, Kate, Kaldor, John M., Dore, Gregory J, Hellard, Margaret, Grebely, Jason
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577441/
https://ncbi.nlm.nih.gov/pubmed/26115881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.05.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars